LifeMD, Inc. (LFMD)
NASDAQ: LFMD · IEX Real-Time Price · USD
6.62
-0.18 (-2.65%)
At close: Jul 2, 2024, 4:00 PM
6.80
+0.18 (2.72%)
After-hours: Jul 2, 2024, 7:39 PM EDT
LifeMD Revenue
LifeMD had revenue of $163.56M in the twelve months ending March 31, 2024, with 32.85% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $44.14M with 33.26% year-over-year growth. In the year 2023, LifeMD had annual revenue of $152.55M with 28.15% growth.
Revenue (ttm)
$163.56M
Revenue Growth
+32.85%
P/S Ratio
1.68
Revenue / Employee
$790,169
Employees
207
Market Cap
275.14M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 152.55M | 33.51M | 28.15% |
Dec 31, 2022 | 119.03M | 26.16M | 28.16% |
Dec 31, 2021 | 92.88M | 55.58M | 149.04% |
Dec 31, 2020 | 37.29M | 24.83M | 199.10% |
Dec 31, 2019 | 12.47M | 4.14M | 49.79% |
Dec 31, 2018 | 8.32M | 4.64M | 126.09% |
Dec 31, 2017 | 3.68M | -1.56M | -29.72% |
Dec 31, 2016 | 5.24M | 4.02M | 329.79% |
Dec 31, 2015 | 1.22M | 504.70K | 70.67% |
Dec 31, 2014 | 714.16K | -94.21K | -11.65% |
Dec 31, 2013 | 808.36K | 134.59K | 19.97% |
Dec 31, 2012 | 673.78K | -70.05K | -9.42% |
Dec 31, 2011 | 743.83K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Accolade | 431.53M |
Procaps Group | 414.10M |
Amarin Corporation | 277.46M |
Tactile Systems Technology | 276.67M |
Kamada | 149.55M |
Alimera Sciences | 90.22M |
Poseida Therapeutics | 82.50M |
Opthea | 385.28K |
LFMD News
- 7 days ago - LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - GlobeNewsWire
- 22 days ago - LifeMD to Participate in the Truist Securities Healthcare Disruptors & Digital Health Summit - GlobeNewsWire
- 7 weeks ago - SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of LifeMD, Inc. (NASDAQ: LFMD) - PRNewsWire
- 2 months ago - LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition - GlobeNewsWire
- 2 months ago - LifeMD Appoints Dr. Calum MacRae to its Board of Directors - GlobeNewsWire
- 2 months ago - LifeMD to Report First Quarter 2024 Financial Results on May 8 - GlobeNewsWire
- 3 months ago - LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 months ago - LifeMD Reports Fourth Quarter 2023 Results - GlobeNewsWire